We are live on
!
Find out more
PIM
Platinum Investment Management Portfolio holdings
AUM
$397M
1-Year Est. Return
63.96%
This Fund
S&P 500
This Quarter
Est. Return
-2.99%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$1.7B
AUM Growth
-$507M
(-23%)
Cap. Flow
-$382M
Cap. Flow
% of AUM
-22.43%
Top 10 Holdings %
Top 10 Hldgs %
66.15%
Holding
139
New
17
Increased
28
Reduced
53
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$25.8M |
| 2 |
Nice
NICE
|
+$21M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$18.3M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$16.6M |
| 5 |
SLB Ltd
SLB
|
+$13.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cameco
CCJ
|
+$102M |
| 2 |
ZTO Express
ZTO
|
+$77M |
| 3 |
Pinduoduo
PDD
|
+$68.4M |
| 4 |
Microchip Technology
MCHP
|
+$57.6M |
| 5 |
Trip.com Group
TCOM
|
+$51.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.1% |
| 2 | Technology | 16.24% |
| 3 | Industrials | 13.83% |
| 4 | Communication Services | 13.45% |
| 5 | Energy | 13.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Keros Therapeutics
KROS
$212M
| – | – |
-20,293
| Closed | -$1.18M |
|
127
Manhattan Associates
MANH
$11.4B
| – | – |
-1,532
| Closed | -$431K |
|
128
908 Devices
MASS
$361M
| – | – |
-257,423
| Closed | -$893K |
|
129
Mobileye
MBLY
$2.21B
| – | – |
-111,659
| Closed | -$1.53M |
|
|
130
Microchip Technology
MCHP
$44.2B
| – | – |
-717,761
| Closed | -$57.6M |
|
131
NXP Semiconductors
NXPI
$58.9B
| – | – |
-3,406
| Closed | -$817K |
|
132
Oracle
ORCL
$435B
| – | – |
-20,151
| Closed | -$3.43M |
|
133
Sarepta Therapeutics
SRPT
$1.81B
| – | – |
-8,001
| Closed | -$999K |
|
134
AT&T
T
$165B
| – | – |
-4,258
| Closed | -$93.7K |
|
135
Q32 Bio
QTTB
$466M
| – | – |
-66,801
| Closed | -$2.98M |
|
|
BIOA
136
BioAge Labs
BIOA
$526M
| – | – |
-50,000
| Closed | -$1.04M |
|
|
OMGA
137
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| – | – |
-346,352
| Closed | -$423K |
|
|
EXAI
138
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| – | – |
-1,456,058
| Closed | -$7.11M |
|
|
LBPH
139
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| – | – |
-103,858
| Closed | -$3.46M |
|
Similar funds
LCG
EH
TPWA
VC
IVLAV
GPC
BA
FI
Platinum Investment Management's Q4 2024 Portfolio in Review
As of Q4 2024, Platinum Investment Management held 139 positions worth $1.7B, down 23% from $2.21B the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Platinum Investment Management withdrew a net $382M in Q4 2024, closing 24 positions and reducing 53 holdings. Its most notable exit was Microchip Technology, an estimated $57.6M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
Against the trend, Platinum Investment Management opened a new position in ProQR Therapeutics worth $4.08M.
- Platinum Investment Management's largest Q4 2024 buy was ProQR Therapeutics: 1,538,247 shares worth $4.08M.
- Platinum Investment Management added most to Broadcom in Q4 2024, an estimated $25.8M increase.
- Platinum Investment Management's biggest Q4 2024 reduction was Cameco, cutting an estimated $102M.
- Platinum Investment Management fully exited Microchip Technology in Q4 2024, selling an estimated $57.6M.
- Platinum Investment Management's ten largest holdings make up 66% of its $1.7B portfolio in Q4 2024.
- Platinum Investment Management opened 17 new positions and closed 24 in Q4 2024.
- Platinum Investment Management's portfolio value fell 23% quarter-over-quarter to $1.7B.
Based on Platinum Investment Management's 13F filing for Q4 2024, filed 11 Feb 2025.